Venus Remedies announced on Monday that it has obtained good manufacturing practises (GMF) certification from the Saudi drug regulator for its Baddi, Himachal Pradesh, production facilities...
Dr Reddy's Laboratories Ltd announced that its subsidiary has entered into a definitive agreement to acquire Australia-based Mayne Pharma Group Limited's US generic prescription product portfolio for USD 105 million. According to a press release...
The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test capable of distinguishing and detecting influenza A and B, also known as the flu, and...
Track and trace in the pharmaceutical sector are connected to the merits related to the efficiency of the manufacturer & the prevention of the entry of counterfeit drugs.
Government is speaking with stakeholders to discover ambitious projects and define the role of industry in executing its recent budget proposal, which is intended to advance research and innovation in pharmaceutical industry.
ASLAN Pharmaceuticals entered into a definitive purchase agreement with BVF Partners, K2 Health Ventures, and certain existing investors to raise gross proceeds of $20 million through the sale of shares (112.3M shares equivalent to 22.5M ADSs at a...
UiPath , a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, a leading Japanese pharmaceuticals company, has turned to the UiPath Business Automation Platform to improve business operational...
Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the approval of wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for ...
RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines, and GenScript ProBio, a leading global Contract Development and Manufacturing Organization...
The asset management arm of India's Kotak Mahindra Group said it will invest 10.70 billion rupees ($129 million) in Biocon Ltd to help it fund its acquisition of Viatris Inc's biosimilars business. In late November, Biocon Biologics completed...